Which has higher valuation and earnings, ARDT or BLLN?

Ardent Health has higher revenue and earnings than Billiontoone. Ardent Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ardent Health $6.32B 0.25 $135.81M $0.95 11.70 Billiontoone $305.11M 22.61 $7.45M $0.55 272.67

Does the media prefer ARDT or BLLN?

In the previous week, Billiontoone had 7 more articles in the media than Ardent Health. MarketBeat recorded 15 mentions for Billiontoone and 8 mentions for Ardent Health. Billiontoone's average media sentiment score of 0.52 beat Ardent Health's score of 0.09 indicating that Billiontoone is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ardent Health 4 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Billiontoone 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, ARDT or SHC?

Ardent Health has higher revenue and earnings than Sotera Health. Ardent Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ardent Health $6.32B 0.25 $135.81M $0.95 11.70 Sotera Health $1.16B 4.41 $77.94M $0.41 43.85

Does the media refer more to ARDT or SHC?

In the previous week, Ardent Health and Ardent Health both had 8 articles in the media. Sotera Health's average media sentiment score of 1.23 beat Ardent Health's score of 0.09 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ardent Health 4 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sotera Health 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, RDNT or ARDT?

Ardent Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RadNet $2.04B 2.58 -$18.65M -$0.18 N/A Ardent Health $6.32B 0.25 $135.81M $0.95 11.70

Is RDNT or ARDT more profitable?

Ardent Health has a net margin of 1.22% compared to RadNet's net margin of -0.66%. Ardent Health's return on equity of 10.45% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.66% 2.77% 0.97% Ardent Health 1.22% 10.45% 3.36%

Does the media favor RDNT or ARDT?

In the previous week, Ardent Health had 4 more articles in the media than RadNet. MarketBeat recorded 8 mentions for Ardent Health and 4 mentions for RadNet. RadNet's average media sentiment score of 0.68 beat Ardent Health's score of 0.09 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ardent Health 4 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, VCYT or ARDT?

Ardent Health has higher revenue and earnings than Veracyte. Ardent Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Veracyte $561.90M 6.60 $66.35M $1.41 32.73 Ardent Health $6.32B 0.25 $135.81M $0.95 11.70

Does the media prefer VCYT or ARDT?

In the previous week, Veracyte had 15 more articles in the media than Ardent Health. MarketBeat recorded 23 mentions for Veracyte and 8 mentions for Ardent Health. Veracyte's average media sentiment score of 0.37 beat Ardent Health's score of 0.09 indicating that Veracyte is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 8 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Ardent Health 4 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to ARDT or CAI?

In the previous week, Ardent Health and Ardent Health both had 8 articles in the media. Caris Life Sciences' average media sentiment score of 1.63 beat Ardent Health's score of 0.09 indicating that Caris Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ardent Health 4 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Caris Life Sciences 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Ardent Health (ARDT) Competitors

$11.12 +0.37 (+3.40%)

Closing price 03:59 PM Eastern

Extended Trading

$11.16 +0.05 (+0.45%)

As of 07:34 PM Eastern

Compare

ARDT vs. BLLN, SHC, RDNT, VCYT, and CAI

Should you buy Ardent Health stock or one of its competitors? MarketBeat compares Ardent Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ardent Health include Billiontoone (BLLN), Sotera Health (SHC), RadNet (RDNT), Veracyte (VCYT), and Caris Life Sciences (CAI).

How does Ardent Health compare to Billiontoone?

Ardent Health (NYSE:ARDT) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation.

Ardent Health has higher revenue and earnings than Billiontoone. Ardent Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ardent Health	$6.32B	0.25	$135.81M	$0.95	11.70
Billiontoone	$305.11M	22.61	$7.45M	$0.55	272.67

Ardent Health has a net margin of 1.22% compared to Billiontoone's net margin of 0.00%. Ardent Health's return on equity of 10.45% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ardent Health	1.22%	10.45%	3.36%
Billiontoone	N/A	N/A	N/A

Ardent Health presently has a consensus price target of $14.04, indicating a potential upside of 26.33%. Billiontoone has a consensus price target of $126.00, indicating a potential downside of 15.98%. Given Ardent Health's higher probable upside, research analysts clearly believe Ardent Health is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Billiontoone had 7 more articles in the media than Ardent Health. MarketBeat recorded 15 mentions for Billiontoone and 8 mentions for Ardent Health. Billiontoone's average media sentiment score of 0.52 beat Ardent Health's score of 0.09 indicating that Billiontoone is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ardent Health	4 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Billiontoone	6 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Ardent Health beats Billiontoone on 8 of the 13 factors compared between the two stocks.

How does Ardent Health compare to Sotera Health?

Ardent Health (NYSE:ARDT) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

91.0% of Sotera Health shares are owned by institutional investors. 1.9% of Ardent Health shares are owned by company insiders. Comparatively, 15.4% of Sotera Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Ardent Health has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market. Comparatively, Sotera Health has a beta of 1.77, meaning that its stock price is 77% more volatile than the broader market.

Sotera Health has a net margin of 9.91% compared to Ardent Health's net margin of 1.22%. Sotera Health's return on equity of 39.73% beat Ardent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ardent Health	1.22%	10.45%	3.36%
Sotera Health	9.91%	39.73%	7.05%

Ardent Health presently has a consensus target price of $14.04, suggesting a potential upside of 26.33%. Sotera Health has a consensus target price of $20.25, suggesting a potential upside of 12.63%. Given Ardent Health's higher possible upside, research analysts clearly believe Ardent Health is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

In the previous week, Ardent Health and Ardent Health both had 8 articles in the media. Sotera Health's average media sentiment score of 1.23 beat Ardent Health's score of 0.09 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ardent Health	4 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sotera Health	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Ardent Health has higher revenue and earnings than Sotera Health. Ardent Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ardent Health	$6.32B	0.25	$135.81M	$0.95	11.70
Sotera Health	$1.16B	4.41	$77.94M	$0.41	43.85

Summary

Sotera Health beats Ardent Health on 11 of the 15 factors compared between the two stocks.

How does Ardent Health compare to RadNet?

RadNet (NASDAQ:RDNT) and Ardent Health (NYSE:ARDT) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.

Ardent Health has a net margin of 1.22% compared to RadNet's net margin of -0.66%. Ardent Health's return on equity of 10.45% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Ardent Health	1.22%	10.45%	3.36%

In the previous week, Ardent Health had 4 more articles in the media than RadNet. MarketBeat recorded 8 mentions for Ardent Health and 4 mentions for RadNet. RadNet's average media sentiment score of 0.68 beat Ardent Health's score of 0.09 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ardent Health	4 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

RadNet has a beta of 1.36, suggesting that its stock price is 36% more volatile than the broader market. Comparatively, Ardent Health has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market.

Ardent Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.58	-$18.65M	-$0.18	N/A
Ardent Health	$6.32B	0.25	$135.81M	$0.95	11.70

77.9% of RadNet shares are held by institutional investors. 5.1% of RadNet shares are held by insiders. Comparatively, 1.9% of Ardent Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

RadNet presently has a consensus target price of $87.43, suggesting a potential upside of 30.37%. Ardent Health has a consensus target price of $14.04, suggesting a potential upside of 26.33%. Given RadNet's stronger consensus rating and higher possible upside, research analysts clearly believe RadNet is more favorable than Ardent Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	2 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.80
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

Summary

Ardent Health beats RadNet on 9 of the 17 factors compared between the two stocks.

How does Ardent Health compare to Veracyte?

Veracyte (NASDAQ:VCYT) and Ardent Health (NYSE:ARDT) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk, analyst recommendations and media sentiment.

Veracyte currently has a consensus price target of $54.33, indicating a potential upside of 17.73%. Ardent Health has a consensus price target of $14.04, indicating a potential upside of 26.33%. Given Ardent Health's higher probable upside, analysts plainly believe Ardent Health is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veracyte	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

Veracyte has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market. Comparatively, Ardent Health has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market.

Veracyte has a net margin of 20.37% compared to Ardent Health's net margin of 1.22%. Ardent Health's return on equity of 10.45% beat Veracyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veracyte	20.37%	9.26%	8.61%
Ardent Health	1.22%	10.45%	3.36%

In the previous week, Veracyte had 15 more articles in the media than Ardent Health. MarketBeat recorded 23 mentions for Veracyte and 8 mentions for Ardent Health. Veracyte's average media sentiment score of 0.37 beat Ardent Health's score of 0.09 indicating that Veracyte is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veracyte	8 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
Ardent Health	4 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Ardent Health has higher revenue and earnings than Veracyte. Ardent Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veracyte	$561.90M	6.60	$66.35M	$1.41	32.73
Ardent Health	$6.32B	0.25	$135.81M	$0.95	11.70

Summary

Veracyte beats Ardent Health on 10 of the 15 factors compared between the two stocks.

How does Ardent Health compare to Caris Life Sciences?

Ardent Health (NYSE:ARDT) and Caris Life Sciences (NASDAQ:CAI) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

Caris Life Sciences has a net margin of 3.75% compared to Ardent Health's net margin of 1.22%. Caris Life Sciences' return on equity of 98.28% beat Ardent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ardent Health	1.22%	10.45%	3.36%
Caris Life Sciences	3.75%	98.28%	48.87%

In the previous week, Ardent Health and Ardent Health both had 8 articles in the media. Caris Life Sciences' average media sentiment score of 1.63 beat Ardent Health's score of 0.09 indicating that Caris Life Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ardent Health	4 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Caris Life Sciences	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Ardent Health has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market. Comparatively, Caris Life Sciences has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market.

Ardent Health presently has a consensus target price of $14.04, indicating a potential upside of 26.33%. Caris Life Sciences has a consensus target price of $26.11, indicating a potential upside of 58.73%. Given Caris Life Sciences' stronger consensus rating and higher possible upside, analysts plainly believe Caris Life Sciences is more favorable than Ardent Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

Ardent Health has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ardent Health	$6.32B	0.25	$135.81M	$0.95	11.70
Caris Life Sciences	$812.03M	5.73	-$68.09M	-$7.61	N/A

Summary

Caris Life Sciences beats Ardent Health on 7 of the 13 factors compared between the two stocks.

Get Ardent Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ARDT vs. The Competition

Export

Metric	Ardent Health	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.54B	$9.86B	$6.87B	$24.09B
Dividend Yield	N/A	2.56%	2.60%	3.70%
P/E Ratio	20.21	23.23	221.61	29.07
Price / Sales	0.25	4.83	596.81	21.16
Price / Cash	3.91	125.06	71.79	32.38
Price / Book	0.94	5.24	12.97	6.92
Net Income	$135.81M	$312.25M	$3.49B	$1.07B
7 Day Performance	1.65%	1.11%	3.57%	2.63%
1 Month Performance	3.52%	-0.73%	-2.50%	1.55%
1 Year Performance	4.07%	25.06%	73.94%	19.52%

Ardent Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ARDT Ardent Health	4.4241 of 5 stars	$11.12 +3.4%	$14.04 +26.3%	+4.1%	$1.54B	$6.32B	20.21	25,200	News Coverage Earnings Report Gap Up
BLLN Billiontoone	2.3126 of 5 stars	$132.04 +3.2%	$126.00 -4.6%	N/A	$6.07B	$305.11M	239.90	620	News Coverage Earnings Report Insider Trade
SHC Sotera Health	3.362 of 5 stars	$17.56 +1.8%	$20.25 +15.4%	+60.5%	$5.00B	$1.19B	42.77	3,000	Positive News Upcoming Earnings
RDNT RadNet	3.2691 of 5 stars	$62.36 +1.4%	$87.43 +40.2%	+24.1%	$4.92B	$2.04B	N/A	11,264	Positive News Upcoming Earnings
VCYT Veracyte	3.8829 of 5 stars	$56.14 +0.9%	$55.88 -0.5%	+90.8%	$4.48B	$517.15M	51.54	790	Positive News Earnings Report Analyst Forecast Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ARDT) was last updated on 8/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ardent Health (ARDT) Competitors

ARDT vs. BLLN, SHC, RDNT, VCYT, and CAI

How does Ardent Health compare to Billiontoone?

Summary

How does Ardent Health compare to Sotera Health?

Summary

How does Ardent Health compare to RadNet?

Summary

How does Ardent Health compare to Veracyte?

Summary

How does Ardent Health compare to Caris Life Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARDT vs. The Competition

Ardent Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ardent Health (ARDT) Competitors

ARDT vs. BLLN, SHC, RDNT, VCYT, and CAI

How does Ardent Health compare to Billiontoone?

Which has higher valuation and earnings, ARDT or BLLN?

Is ARDT or BLLN more profitable?

Do analysts prefer ARDT or BLLN?

Does the media prefer ARDT or BLLN?

Summary

How does Ardent Health compare to Sotera Health?

Do insiders & institutionals hold more shares of ARDT or SHC?

Which has more risk and volatility, ARDT or SHC?

Is ARDT or SHC more profitable?

Do analysts rate ARDT or SHC?

Does the media refer more to ARDT or SHC?

Which has preferable valuation & earnings, ARDT or SHC?

Summary

How does Ardent Health compare to RadNet?

Is RDNT or ARDT more profitable?

Does the media favor RDNT or ARDT?

Which has more volatility & risk, RDNT or ARDT?

Which has preferable earnings & valuation, RDNT or ARDT?

Do insiders and institutionals believe in RDNT or ARDT?

Do analysts recommend RDNT or ARDT?

Summary

How does Ardent Health compare to Veracyte?

Do analysts recommend VCYT or ARDT?

Which has more risk & volatility, VCYT or ARDT?

Is VCYT or ARDT more profitable?

Does the media prefer VCYT or ARDT?

Which has stronger valuation & earnings, VCYT or ARDT?

Summary

How does Ardent Health compare to Caris Life Sciences?

Is ARDT or CAI more profitable?

Does the media refer more to ARDT or CAI?

Which has more volatility and risk, ARDT or CAI?

Do analysts prefer ARDT or CAI?

Which has higher earnings & valuation, ARDT or CAI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARDT vs. The Competition

Ardent Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools